Previous Close | 39.97 |
Open | 39.69 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 39.69 - 39.73 |
52 Week Range | 39.69 - 39.73 |
Volume | |
Avg. Volume | N/A |
Net Assets | N/A |
NAV | N/A |
PE Ratio (TTM) | N/A |
Yield | N/A |
YTD Daily Total Return | N/A |
Beta (5Y Monthly) | N/A |
Expense Ratio (net) | N/A |
Inception Date | N/A |
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
MAESTRO-NAFLD-1 late-breaker and three other Madrigal abstracts accepted for oral presentation at the EASL International Liver Congress™Data from the Phase 3 MAESTRO-NAFLD-1 study continue to reinforce the safety and efficacy profiles of resmetiromMadrigal remains on track to disclose topline data from MAESTRO-NASH in the fourth quarter and anticipates filing for accelerated approval under Subpart H next yearPlanned MAESTRO-NASH Outcomes trial, a non-invasive Phase 3 study designed to accelerate